Original Investigation
Pathogenesis and Treatment of Kidney Disease
Sequence of Progression of Albuminuria and Decreased GFR in Persons With Type 1 Diabetes: A Cohort Study

https://doi.org/10.1053/j.ajkd.2007.08.005Get rights and content

Background

The sensitivity of albuminuria in predicting loss of kidney function has been questioned. We determined the sequence of kidney disease stages (microalbuminuria, macroalbuminuria, low estimated glomerular filtration rate [eGFR], and end-stage renal disease [ESRD]) and characterized those without albuminuria before a low eGFR.

Study Design

The Pittsburgh Epidemiology of Diabetes Complications Study is a prospective cohort investigation of childhood-onset type 1 diabetes.

Setting & Participants

480 study participants with eGFR greater than 60 mL/min/1.73 m2 (mean age, 27 years; diabetes duration, 19 years at study entry) were prospectively followed up for 16 years.

Outcomes & Measurements

Low eGFR was defined as creatinine clearance less than 60 mL/min/1.73 m2 from timed urine collections; microalbuminuria, as albumin excretion rate between 20 to 200 μg/min (30 to 300 mg/24 h); macroalbuminuria, as albumin excretion rate greater than 200 μg/min (>300 mg/24 h); and ESRD, as dialysis or renal transplantation.

Results

The 33 of 480 individuals (7%) who developed ESRD had prior albuminuria. 71 of 480 (15%) individuals developed low eGFR. 66 of 71 (93%) had prior/concurrent albuminuria, and 5 of 71 (7%) did not. Incident low eGFR values in the 5 patients were: (1) 54, (2) 58, (3) 59, (4) 59.7, and (5) 59.8 mL/min/1.73 m2. 3 of 5 (60%; patients 1, 4, and 5) subsequently developed albuminuria. Final eGFRs in the 5 patients were: (1) 94, (2) 86, (3) 60, (4) 65, and (5) 54 mL/min/1.73 m2, respectively.

Limitations

GFR and insulin sensitivity were not measured, but estimated. Incident decreased eGFR in patients without preceding/concurrent albuminuria may be caused by misclassification or a temporary eGFR decrease.

Conclusions

Moderately decreased eGFR may occur rarely in patients with type 1 diabetes without preceding albuminuria.

Section snippets

Methods

Participants in the Pittsburgh Epidemiology of Diabetes Complications (EDC) Study, a 16-year prospective investigation of patients with childhood-onset (age < 17 years) type 1 diabetes, who had normal eGFR (defined as 24-hour creatinine clearance >60 mL/min/1.73 m2 [>1.0 mL/s/1.73 m2] at baseline assessment; n = 480) were selected for study. These individuals had been given a diagnosis or been seen within 1 year of diagnosis at Children’s Hospital of Pittsburgh from 1950 to 1980 and were

Results

Characteristics of individuals with normal eGFR at time of first evaluation in the EDC Study are listed in Table 1, categorized by level of albuminuria. As expected, individuals with microalbuminuria or macroalbuminuria were older and had longer duration of diabetes and higher blood pressure and lipid and inflammatory marker levels, but lower eGDR. They were also more likely to have other diabetes complications at baseline. Similar results were obtained after age adjustment.

Discussion

Recently, the question was raised whether albuminuria regularly precedes the loss of GFR in patients with diabetic kidney disease.1, 2, 3 Thus, we assessed the sequence in which albuminuria, decreased GFR, and ESRD occurred in a cohort of childhood-onset type 1 diabetes. We found that all subjects who developed ESRD had prior albuminuria. Nonetheless, although the majority of individuals without albuminuria or low eGFR at study entry remained without these abnormalities (n = 182; 64%) or

Acknowledgements

We thank Dr Dorothy Becker for assistance with recruitment of the cohort and HbA1 measurements and all study participants for their invaluable contributions.

Support: This research was funded by National Institutes of Health grant DK34818.

Financial Disclosure: None.

References (51)

  • R.J. Tapp et al.

    Albuminuria is evident in the early stages of diabetes onset: Results from the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab)

    Am J Kidney Dis

    (2004)
  • D. Ellis et al.

    The changing course of diabetic nephropathy: Low-density lipoprotein cholesterol and blood pressure correlate with regression of proteinuria

    Am J Kidney Dis

    (1996)
  • R. Retnakaran et al.

    Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74

    Diabetes

    (2006)
  • H.J. Kramer et al.

    Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus

    JAMA

    (2003)
  • M.E. Molitch et al.

    Renal insufficiency in the absence of albuminuria among adults with type 1 diabetes in the Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Study

    Diabetes

    (2006)
  • Incidence of end-stage renal disease among persons with diabetes—United States, 1990-2002

    MMWR Morb Mortal Wkly Rep

    (2005)
  • T.J. Orchard et al.

    Prevalence of complications of IDDM by sex and duration: Pittsburgh Epidemiology of Diabetes Complications Study II

    Diabetes

    (1990)
  • T.J. Orchard et al.

    Factors associated with the avoidance of severe complications after 25 years of insulin dependent diabetes mellitus: Pittsburgh Epidemiology of Diabetes Complications Study–I

    Diabetes Care

    (1990)
  • D.K. Wagener et al.

    The Pittsburgh Study of insulin-dependent diabetes mellitus: Risk for diabetes among relatives of IDDM

    Diabetes

    (1982)
  • N.O. Borhani et al.

    The hypertension detection and follow-up program

    Prev Med

    (1976)
  • G.R. Warnick et al.

    Heparin-Mn2+ quantitation of high density lipoprotein cholesterol: An ultrafiltration procedure for lipemic samples

    Clin Chem

    (1978)
  • Lipid Research Clinics Program

    (1975)
  • C.C. Allain et al.

    Enzymatic determination of total serum cholesterol

    Clin Chem

    (1974)
  • G. Bucolo et al.

    Quantitative determination of serum triglycerides by the use of enzymes

    Clin Chem

    (1973)
  • W.T. Friedewald et al.

    Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge

    Clin Chem

    (1972)
  • Cited by (55)

    • Diabetic Kidney Disease

      2020, Primary Care - Clinics in Office Practice
      Citation Excerpt :

      For T2DM, approximately 30% of patients develop microalbuminuria within 10 years of diabetes diagnosis, and approximately 5% progress to overt nephropathy every year.7 Nearly all patients with low GFR from DKD have preceding albuminuria, and the degree of albuminuria predicts the rate of GFR decline.8–11 Effective hyperglycemia and hypertension management can delay the onset of microalbuminuria and slow DKD progression.

    • Pathophysiology of Diabetic Nephropathy

      2019, Chronic Renal Disease
    • Predictors of renal complications in pediatric patients with type 1 diabetes mellitus: A prospective cohort study

      2018, Journal of Diabetes and its Complications
      Citation Excerpt :

      Microalbuminuria is widely used as a screening tool for diabetic nephropathy, even if renal impairment can occur in absence of albuminuria. A prospective cohort study in childhood-onset diabetes reported that 5% of subjects with low estimated glomerular filtration rate did not have prior albuminuria.15 However, microalbuminuria still remains the reliable marker of renal damage and all patients must be screened14, even before young adulthood to ascertain incipient damage and to assess stricter glycometabolic control follow-up.16

    • Association between circulating adipocytokine concentrations and microvascular complications in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of controlled cross-sectional studies

      2016, Journal of Diabetes and its Complications
      Citation Excerpt :

      Nephropathy has a prevalence of approximately 30% in patients with diabetes; it is associated with vascular injury in the nephrons, affecting renal function at different levels. Serious nephropathy can evolve into chronic kidney disease and eventual end-stage renal disease, meaning these patients must either enter long-term haemodialysis or require renal transplantation (Costacou, Ellis, Fried, & Orchard, 2007). Neuropathy is associated with vascular and neuronal damage (commonly peripheral, but also autonomic), leading to impairment of sensation, movement or organ/gland control.

    View all citing articles on Scopus

    Originally published online as doi:10.1053/j.ajkd.2007.08.005 on October 3, 2007.

    View full text